Clinical trial
A Multi-center, Randomized, Double-blinded, Phase 3 Trial to Evaluate the Efficacy Against Herpes Zoster of a Live Attenuated Varicella-Zoster Virus Vaccine in Adults Over 40 Years of Age
NCT03314103 is registered in ClinicalTrials.gov with Jiangsu Province Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double-blinded, Phase 3 Trial to Evaluate the Efficacy Against Herpes Zoster of a Live Attenuated Varicella-Zoster Virus Vaccine in Adults Over 40 Years of Age
- Lead sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 6, 2017
- Completion date
- January 19, 2019
- Enrollment
- 30,000 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.